BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35817006)

  • 1. Reply to Letter "Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome".
    Senderovich H; Patel P; Jimenez Lopez B; Waicus S
    Med Princ Pract; 2022; 31(5):499-500. PubMed ID: 35817006
    [No Abstract]   [Full Text] [Related]  

  • 2. Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome.
    Bonnet U
    Med Princ Pract; 2022; 31(5):497-498. PubMed ID: 35817019
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabinoid hyperemesis syndrome.
    Galli JA; Sawaya RA; Friedenberg FK
    Curr Drug Abuse Rev; 2011 Dec; 4(4):241-9. PubMed ID: 22150623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid Hyperemesis Syndrome: A Review of the Presentation and Treatment.
    Leu N; Routsolias JC
    J Emerg Nurs; 2021 May; 47(3):483-486. PubMed ID: 33712244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse].
    Naver AV; Theede K
    Ugeskr Laeger; 2015 Apr; 177(18):. PubMed ID: 25922240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology.
    Iacopetti CL; Packer CD
    Clin Med Res; 2014 Sep; 12(1-2):65-7. PubMed ID: 24667219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural language processing improves estimates of the epidemiology of cannabinoid hyperemesis syndrome.
    Hewitt M; Ma P; Coyle E; Leidlein S; Jennings K; Wanis N; Miller J
    Am J Emerg Med; 2023 Aug; 70():198-199. PubMed ID: 37349236
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department.
    Wightman RS; Metrik J; Lin TR; Collins AB; Beaudoin FL
    Acad Emerg Med; 2024 May; 31(5):463-470. PubMed ID: 37387520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
    Inayat F; Virk HU; Ullah W; Hussain Q
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28052951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid hyperemesis syndrome masquerading as an eating disorder.
    Brewerton TD; Anderson O
    Int J Eat Disord; 2016 Aug; 49(8):826-9. PubMed ID: 26842268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice.
    Kast KA; Gershengoren L
    J Psychiatr Pract; 2018 Jan; 24(1):51-55. PubMed ID: 29320384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles of Emergency Department Patients With Suspected Cannabinoid Hyperemesis Syndrome.
    Wightman RS; Metrik J; Lin TR; Li Y; Badea A; Almeida R; Collins AB; Beaudoin FL
    Ann Emerg Med; 2023 Aug; 82(2):121-130. PubMed ID: 37479395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hair cannabinoid concentrations in emergency patients with cannabis hyperemesis syndrome.
    Albert K; Sivilotti MLA; Gareri J; Day A; Ruberto AJ; Hookey LC
    CJEM; 2019 Jul; 21(4):477-481. PubMed ID: 30806339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid hyperemesis syndrome: a case series and review of previous reports.
    Nicolson SE; Denysenko L; Mulcare JL; Vito JP; Chabon B
    Psychosomatics; 2012; 53(3):212-9. PubMed ID: 22480624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cannabinoid hyperemesis syndrome: about 6 cases].
    Bertolino J; Abdo L; Khau D; Meckenstock R; Sautereau N; Jean E; Greder-Belan A; Frances Y; Cabane J; Granel B
    Rev Med Interne; 2015 Oct; 36(10):694-7. PubMed ID: 25547957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure.
    Argamany JR; Reveles KR; Duhon B
    Am J Emerg Med; 2016 Apr; 34(4):765.e1-2. PubMed ID: 26422191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid hyperemesis: a case series.
    Donnino MW; Cocchi MN; Miller J; Fisher J
    J Emerg Med; 2011 Apr; 40(4):e63-6. PubMed ID: 19765941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid Hyperemesis Syndrome in Pediatrics: An Emerging Problem.
    Dosani K; Koletic C; Alhosh R
    Pediatr Rev; 2021 Sep; 42(9):500-506. PubMed ID: 34470869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
    Hickey JL; Witsil JC; Mycyk MB
    Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cannabinoid hyperemesis syndromecan be relieved by hot showers].
    Søndermølle MB; Randers E
    Ugeskr Laeger; 2021 Apr; 183(15):. PubMed ID: 33913422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.